-
Amiculum
- Who we are
- What we do
-
Insights
- What does impactful medical education look like for rare diseases
- Can we trust LLMs to provide appropriate medical advice?
- Amiculum insights podcast: highlights from ISMPP Europe 2026
- From ‘why’ to ‘how’: patient partnership across age groups in research and publications
- Turn payer insights into impact with omnichannel engagement in market access
- How can pharma build genuine partnerships with patient communities?
- What will healthcare communications look like in 2026? Amiculum’s prediction of upcoming trends
- Winning in Pharma: the power of early strategic planning with patients
- Amiculum earns EcoVadis silver medal for the 3rd year running
- AI persona generation for healthcare: quick wins & real-world impact
- VuuAI and Amiculum partner to transform content engagement in pharma
- Adapting market access strategies: Practical takeaways from ISPOR Europe
- What defines the ideal therapy today? Insights from PharmaQuest at ISPOR Europe
- Can AI drive efficiency in systematic literature reviews?
- Is Joint Clinical Assessment (JCA) appropriate for assessing the broader value of vaccines?
- AI in Pharma: Insights from GlobalLink NEXT London 2025
- Amiculum: new brand, same great team!
- Is AI the answer? Translating complex medical information into public understanding
- Unlocking the future of Learning
- Life at Amiculum: Our global gathering
- Real-world implementation of AI in medical affairs: Vision, value and collaboration
- Why healthcare communications needs creativity, now more than ever
- The (clinical) trials and tribulations of gene therapy - why meaningful patient engagement strategies matter
- Data visualization: translating complex data into emotive storytelling
- What do people look for in gene therapy materials? Results from our survey of patients and relatives
- Life at Amiculum: through the eyes of our team
- What’s next for scientific congress booths: five trends for 2025
- Amiculum supports Lung Cancer Europe’s ‘Get Checked!’ campaign for Lung Cancer Awareness Month
- Can AI reliably replace human reviewers in literature reviews?
- Stacking the odds in your favour with landscape analysis
- Amiculum earns EcoVadis silver award for second consecutive year
- Championing people-powered communications in rare diseases: Amiculum's feature in The Guardian Rare Diseases Campaign 2024
- AI in market access: silver bullet or spanner in the works?
- Answering some of Pharma’s big questions to drive brand strategies
- Unlocking market access success for cell and gene therapies: the vital role of early strategic planning
- Artificial intelligence versus real insight – does pharmaceutical industry consulting face a dilemma or a progression?
- Generative AI, storytelling and patient inclusion: key publications trends in 2024
- Joint Clinical Assessments: bureaucratic nightmare, AI opportunity, or both?
- Eyes on the horizon: six (and a half) predictions for the future of healthcare communications
- Amiculum and the University of Dundee collaborate on a Master’s course in Science and Health Communication
- Do omnichannel approaches have a role in market access and payer discussions?
- Early strategic planning: how to get ahead of the curve
- Enhancing the patient–HCP relationship in rare diseases
- Bringing omnichannel to medical affairs: what do you need to know?
- News
- Join us
- Contact
- Cookie Policy
- Privacy Policy
- Supplier Code of Conduct
- Accessibility Statement
- Terms and Conditions
- Company Details